The role of type-1 and type-2 T-helper immune responses in HTV-1 vaccine protection

Journal of Medical Primatology

Volumn 27, Issue 2-3, 1998, Pages 50-58

  Heeney, Jonathan L ^a   Van Gils, Mariëlle E ^a   Van der Meide, Peter ^a   De Giuli Morghen, Carlo ^b   Ghioni, Cristina ^b   Gimelli, Margherita ^b   Raddelli, Antonio ^b   Davis, David ^d   Åkerblom, Lennart ^c   Morein, Bror ^c  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Immunity; Th1; Th2

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ISCOM; RECOMBINANT VACCINE; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BIOSYNTHESIS; BLOOD; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MACACA; TH1 CELL; TH2 CELL; TIME;

AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; ISCOMS; MACACA MULATTA; TH1 CELLS; TH2 CELLS; TIME FACTORS; VACCINES, SYNTHETIC;

EID: 0032036524     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1998.tb00226.x     Document Type: Article

References (34)

1. BENVENISTE O, VASLIN B, LE-GRAND R, CHERET A, MATHEUX F, THEODORO F, CRANAGE MP, DORMONT D: Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proc Natl Acad Sci USA 93:3658-3663, 1996.
2. BERMAN PW, GREGORY TJ, RIDDLE L, NAKAMURA GR, CHAMPE MA, PORTER JP, WURM FM, HERSHBERG RD, COBB EK, EICHBERG JW: Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345:622-625, 1990.
3. BLOOM BR: A perspective on AIDS vaccines. Science 272:1888-1890, 1996.
4. BOGERS WM, NIPHUIS H, TEN-HAAFT P, LAMAN JD, KOORNSTRA W, HEENEY JL: Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: Consequences of challenge. AIDS 9:F13-F18, 1995.
5. BOGERS WMJM, DUBBES R, TEN HAAFT P, NIPHUIS H, CHENG-MAYER C, STAHL-HENNIG C, HUNSMANN G, KUWATA T, HAYAMI M, JONES S, RANJBAR S, ALMOND N, STOTT J, ROSENWIRTH B, HENNEY JL: Comparison of in vitro and in vivo infectivity of different clade B HTV-1 envelope chimeric simian/human immunodeficiency viruses in Macaco mulatta. Virology 236:110-117, 1997.
6. BRUCK C, THIRIART C, FABRY L, FRANCOTTE M, PALA P, VANOPSTAL O, CULP J, ROSENBERG M, DE-WILDE M, HEIDT P, HEENEY JL: HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12:1141-1148, 1994.
7. CHENG-MAYER C, SHIODA T, LEVY JA: Host range, replicative, and cytopathic properties of human immunodeficiency virus type-1 are determined by very few amino acid changes in tat and gp120. J Virol 65:6931-6941, 1991.
8. DAVIS D, CHAUDHRI B, STEPHENS DM, CARNE CA, WILLERS C, LACHMANN PJ: The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type-1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. J Gen Virol 71:1975-1983, 1990.
9. DAVIS D, MOREIN B, ÅKERBLOM L, VAN GILS ME, BOGERS W, TEEUWSEN V, HEENEY JL: A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen. Vaccine 15:1661-1669, 1997.
10. DAVIS D, STEPHENS DM, WILLERS C, LACHMANN PJ: Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type-1. J Gen Virol 71:2889-2898, 1990.
11. EMINI EA, SCHLEIF WA, NUNBERG JH, CONLEY AJ, EDA Y, TOKIYOSHI S, PUTNEY SD, MATSUSHITA S, COBB KE, JETT CM: Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355:728-730, 1992.
12. FORSTHUBER T, YIP HC, LEHMANN PV: Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728-1730, 1996.
13. FULTZ PN, NARA P, BARRE-SINOUSSI F, CHAPUT A, GREENBERG ML, MUCHMORE E, KIENY MP, GIRARD M: Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256:1687-1690, 1992.
14. GALLIMORE A, CRANAGE M, COOK N, ALMOND N, BOOTMAN J, RUD E, SILVERA P, DENNIS M, CORCORAN T, STOTT J: Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1:1167-1173, 1995.
15. GIRARD M, KIENY MP, PINTER A, BARRE-SINOUSSI F, NARA P, KOLBE H, KUSUMI K, CHAPUT A, REINHART T, MUCHMORE E: Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88:542-546, 1991.
16. HAAFT PJFT, CORNELISSEN M, GOUDSMIT J, KOORNSTRA W, DUBBES R, NIPHUIS H, PEETERS M, THIRIART C, BRUCK C, JEENEY JL: Virus load in chimpanzees infected with human immunodeficiency virus type-1: Effect of pre-exposure vaccination. J Gen Virol 76:1015-1020, 1995.
17. HAYNES BF, PANTALEO G, FAUCI AS: Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324-328, 1996.
18. HEENEY JL: AIDS: a disease of impaired Th-cell renewal? Immunol Today 16:515-520, 1995.
19. HEENEY JL: Primate models for AIDS vaccine development. 10:S115-S122, 1996.
20. HEENEY JL, VAN-E C, DE-VRIES P, TEN-HAAFT P, OTTING N, KOORNSTRA W, BOES J, DUBBES R, NIPHUIS H, DINGS M: Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 180:769-774, 1994.
21. HULSKOTTE EG, GERETTI AM, SIEBELINK KH, VAN-AMERONGEN G, CRANAGE MP, RUD EW, NORLEY SG, DE-VRIES P, OSTERHAUS AD: Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). J Virol 69:6289-6296, 1995.
22. JOAG SV, LI Z, FORESMAN L, STEPHENS EB, ZHAO LJ, ADANY I, PINSON DM, MCCLURE HM, NARAYAN O: Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macques. J Virol 70:3189-3197, 1996.
23. LEHNER T, WANG Y, CRANAGE M, BERGMEIER LA, MITCHELL E, TAO L, HALL G, DENNIS M, COOK N, BROOKES R, KLAVINSKIS L, JONES I, DOYLE C, WARD R: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 2:767-775, 1996.
24. LUCIW PA, PRATT-LOWE E, SHAW KE, LEVY JA, CHENG-MAYER C: Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci USA 92:7490-7494, 1995.
25. MOREIN B, SUNDQUIST B, HOGLUND S, DALSGAARD K, OSTERHAUS A: Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308:457-460, 1984.
26. MOSMANN TR, COFFMAN RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989.
27. MOWAT AM, DONACHIE AM, REID G, JARRETT O: Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72:317-322, 1991.
28. RADAELLI A, DE-GIULI-MORGHEN C: Expression of HIV-1 envelope gene by recombinant avipox viruses. Vaccine 12:1101-1109, 1994.
29. REIMANN KA, LI JT, VOSS G, LEKUTIS C, TENNER-RACZ K, RACZ P, LIN W, MONTEFIORI DC, LEE-PARRITZ DE, LU Y, COLLMAN RG, SODROSKI J, LETVIN NL: An env gene derived from a primary human immunodeficiency virus type-1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol 70:3198-3206, 1996.
30. ROWLAND-JONES SL, SUTTON J, ARIYOSHI K, DONG T, GOTCH F, MCADAM S, WHITBY D, SABALLY S, GALLIMORE A, CORRAH T, TAKIGUCHI M, SCHULTZ T, MCMICHAEL A, WHITTLE H: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1:59-64, 1995.
31. SHEARER GM, CLERICI M: Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 17:21-24, 1996.
32. SHIBATA R, SEIMON C, CHO MW, ARTHUR LO, NIGIDA S, JR., MATTHEWS T, SAWYER LA, SCHULTZ A, MURTHY KK, ISRAEL Z, JAVADIAN A, FROST P, KENNEDY RC, LANE HC, MARTIN MA: Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type-1. J Virol 70:4361-6369, 1996.
33. TOUGH DF, BORROW P, SPRENT J: Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-1950, 1996.
34. VAN DER MEIDE PH, GROENESTEIN RJ, DE LABIE MCDC, HEENEY JL, PALA P, SLAOUI M: Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques. J Med Primatol 24:271-281, 1995.